UnitedHealth Group Financials
| UNH Stock | USD 501.13 7.95 1.61% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Net Profit Margin | 0.0433 | 0.0602 |
|
| |||||
| Return On Assets | 0.0582 | 0.0804 |
|
| |||||
| Return On Equity | 0.26 | 0.2522 |
|
| |||||
| Debt Equity Ratio | 0.62 | 0.7163 |
|
| |||||
| Operating Income | 34 B | 32.4 B |
|
| |||||
| Current Ratio | 1.01 | 0.7919 |
|
|
The financial analysis of UnitedHealth Group is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for UnitedHealth Group includes many different criteria found on its balance sheet. For example, investors should never minimize UnitedHealth Group's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor UnitedHealth Group's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in UnitedHealth Group.
Cash And Equivalents |
|
With this module, you can analyze UnitedHealth financials for your investing period. You should be able to track the changes in UnitedHealth Group individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
UnitedHealth | Select Account or Indicator |
Understanding current and past UnitedHealth Group Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of UnitedHealth Group's financial statements are interrelated, with each one affecting the others. For example, an increase in UnitedHealth Group's assets may result in an increase in income on the income statement.
The data published in UnitedHealth Group's official financial statements usually reflect UnitedHealth Group's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of UnitedHealth Group. For example, before you start analyzing numbers published by UnitedHealth accountants, it's critical to develop an understanding of what UnitedHealth Group's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of UnitedHealth Group's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, UnitedHealth Group's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in UnitedHealth Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of UnitedHealth Group Incorporated. Please utilize our Beneish M Score to check the likelihood of UnitedHealth Group's management manipulating its earnings.
UnitedHealth Group Stock Summary
UnitedHealth Group competes with Certara, HealthStream, Evolent Health, Streamline Health, and Definitive Healthcare. UnitedHealth Group Incorporated operates as a diversified health care company in the United States. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. Unitedhealth operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 350000 people.| Foreign Associates | |
Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| ISIN | US91324P1021 |
| CUSIP | 91324P102 910581107 |
| Location | Minnesota; U.S.A |
| Business Address | UnitedHealth Group Center, |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.unitedhealthgroup.com |
| Phone | 952 936 1300 |
| Currency | USD - US Dollar |
You should never invest in UnitedHealth Group without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of UnitedHealth Stock, because this is throwing your money away. Analyzing the key information contained in UnitedHealth Group's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
UnitedHealth Group Key Financial Ratios
Generally speaking, UnitedHealth Group's financial ratios allow both analysts and investors to convert raw data from UnitedHealth Group's financial statements into concise, actionable information that can be used to evaluate the performance of UnitedHealth Group over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that UnitedHealth Group reports annually and quarterly.| Return On Equity | 0.17 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.08 % |
UnitedHealth Group Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 173.9B | 197.3B | 212.2B | 245.7B | 278.4B | 292.3B | |
| Net Debt | 29.7B | 26.5B | 24.6B | 34.3B | 42.0B | 44.1B | |
| Retained Earnings | 61.2B | 69.3B | 77.1B | 86.2B | 95.8B | 100.6B | |
| Cash | 11.0B | 16.9B | 21.4B | 23.4B | 25.4B | 26.7B | |
| Net Receivables | 11.8B | 12.9B | 14.2B | 17.7B | 39.0B | 40.9B | |
| Other Current Assets | 16.6B | 21.1B | 23.6B | 23.5B | 78.4B | 82.4B | |
| Total Liab | 111.7B | 126.8B | 135.7B | 159.4B | 179.5B | 188.5B | |
| Total Current Assets | 42.6B | 53.7B | 61.8B | 69.1B | 78.4B | 82.4B | |
| Intangible Assets | 10.3B | 10.9B | 10.0B | 14.4B | 15.2B | 16.0B | |
| Other Current Liab | 33.6B | 42.9B | 47.6B | 54.0B | 58.4B | 61.4B | |
| Short Term Debt | 3.9B | 4.8B | 3.6B | 3.1B | 5.3B | 5.6B | |
| Accounts Payable | 21.7B | 21.9B | 24.5B | 29.1B | 32.0B | 33.6B | |
| Good Will | 65.7B | 71.3B | 75.8B | 93.4B | 103.7B | 108.9B | |
| Other Liab | 10.0B | 15.7B | 15.1B | 11.8B | 13.5B | 14.2B | |
| Other Assets | 13.8B | 52.8B | 107.3B | 20.7B | 23.8B | 13.1B | |
| Long Term Debt | 36.8B | 38.6B | 42.4B | 54.5B | 58.3B | 61.2B | |
| Net Tangible Assets | (16.7B) | (14.5B) | 75.0B | (25.1B) | (28.8B) | (27.4B) | |
| Long Term Debt Total | 36.8B | 38.6B | 42.4B | 54.5B | 62.7B | 65.8B |
UnitedHealth Group Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what UnitedHealth Group's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Revenue | 240.3B | 255.6B | 285.3B | 322.1B | 371.6B | 390.2B | |
| Gross Profit | 55.7B | 65.5B | 67.3B | 77.6B | 91.0B | 95.5B | |
| Operating Income | 19.7B | 22.4B | 24.0B | 28.4B | 32.4B | 34.0B | |
| Ebit | 19.7B | 22.4B | 24.0B | 28.4B | 32.4B | 34.0B | |
| Ebitda | 20.5B | 23.8B | 24.7B | 29.8B | 36.3B | 38.1B | |
| Cost Of Revenue | 184.6B | 190.1B | 217.9B | 244.5B | 280.7B | 294.7B | |
| Income Before Tax | 18.0B | 20.7B | 22.3B | 26.3B | 29.1B | 30.6B | |
| Net Income | 13.8B | 15.4B | 17.3B | 20.1B | 22.4B | 23.5B | |
| Income Tax Expense | 3.7B | 5.0B | 4.6B | 5.7B | 6.0B | 6.3B | |
| Interest Expense | 1.7B | 1.7B | 1.7B | 2.1B | 3.2B | 3.4B | |
| Minority Interest | 400M | 366M | (447M) | (519M) | (763M) | (724.9M) | |
| Tax Provision | 3.7B | 5.0B | 4.6B | 5.7B | 6.0B | 5.0B | |
| Interest Income | 1.7B | 1.7B | 1.7B | 2.1B | 2.4B | 1.6B | |
| Net Interest Income | (1.7B) | (1.7B) | (1.7B) | (2.1B) | (3.2B) | (3.1B) |
UnitedHealth Group Key Cash Accounts
Cash flow analysis captures how much money flows into and out of UnitedHealth Group. It measures of how well UnitedHealth is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money UnitedHealth Group brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money UnitedHealth had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what UnitedHealth Group has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 119M | 5.9B | 4.5B | 2.0B | 2.1B | 2.2B | |
| Free Cash Flow | 16.4B | 20.1B | 19.9B | 23.4B | 25.7B | 27.0B | |
| Depreciation | 2.7B | 2.9B | 3.1B | 3.4B | 4.0B | 4.2B | |
| Other Non Cash Items | 294M | (52M) | (944M) | 673M | 258M | 270.9M | |
| Capital Expenditures | 2.1B | 2.1B | 2.5B | 2.8B | 3.4B | 3.6B | |
| Net Income | 14.2B | 15.8B | 17.7B | 20.6B | 22.4B | 23.5B | |
| End Period Cash Flow | 11.0B | 16.9B | 21.4B | 23.4B | 25.4B | 26.7B | |
| Dividends Paid | 3.9B | 4.6B | 5.3B | 6.0B | (6.8B) | (6.4B) | |
| Change To Inventory | (1.6B) | (2.2B) | (1.0B) | 1.0B | 934.2M | 599.3M | |
| Investments | (2.5B) | (2.8B) | (1.8B) | (28.5B) | (15.6B) | (14.8B) | |
| Change Receivables | 162M | (688M) | 1B | (2.5B) | (2.3B) | (2.2B) | |
| Net Borrowings | 4.0B | 2.6B | 2.5B | 12.5B | 14.4B | 15.1B | |
| Change To Netincome | 821M | 619M | 433M | (79M) | (90.9M) | (86.3M) |
UnitedHealth Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining UnitedHealth Group's current stock value. Our valuation model uses many indicators to compare UnitedHealth Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across UnitedHealth Group competition to find correlations between indicators driving UnitedHealth Group's intrinsic value. More Info.UnitedHealth Group Incorporated is rated first in return on equity category among related companies. It is rated first in return on asset category among related companies reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for UnitedHealth Group Incorporated is roughly 2.43 . As of now, UnitedHealth Group's Return On Equity is increasing as compared to previous years.Comparative valuation analysis is a catch-all model that can be used if you cannot value UnitedHealth Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for UnitedHealth Group's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the UnitedHealth Group's earnings, one of the primary drivers of an investment's value.UnitedHealth Group Systematic Risk
UnitedHealth Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. UnitedHealth Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on UnitedHealth Group correlated with the market. If Beta is less than 0 UnitedHealth Group generally moves in the opposite direction as compared to the market. If UnitedHealth Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one UnitedHealth Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of UnitedHealth Group is generally in the same direction as the market. If Beta > 1 UnitedHealth Group moves generally in the same direction as, but more than the movement of the benchmark.
About UnitedHealth Group Financials
What exactly are UnitedHealth Group Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include UnitedHealth Group's income statement, its balance sheet, and the statement of cash flows. Potential UnitedHealth Group investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although UnitedHealth Group investors may use each financial statement separately, they are all related. The changes in UnitedHealth Group's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on UnitedHealth Group's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze UnitedHealth Group Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as UnitedHealth Group is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of UnitedHealth has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if UnitedHealth Group's financials are consistent with your investment objective using the following steps:- Review UnitedHealth Group's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand UnitedHealth Group's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare UnitedHealth Group's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if UnitedHealth Group's stock is overvalued or undervalued.
UnitedHealth Group Thematic Clasifications
UnitedHealth Group Incorporated is part of Obamacare Repeal investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal
This theme covers Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. Get More Thematic Ideas
| Obamacare Repeal | View |
Today, most investors in UnitedHealth Group Stock are looking for potential investment opportunities by analyzing not only static indicators but also various UnitedHealth Group's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of UnitedHealth Group growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
UnitedHealth Group April 20, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of UnitedHealth Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of UnitedHealth Group Incorporated. We use our internally-developed statistical techniques to arrive at the intrinsic value of UnitedHealth Group Incorporated based on widely used predictive technical indicators. In general, we focus on analyzing UnitedHealth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build UnitedHealth Group's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 9.08 | |||
| Value At Risk | (2.48) | |||
| Potential Upside | 2.15 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for UnitedHealth Stock analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.16 | Dividend Share 7.52 | Earnings Share 16.37 | Revenue Per Share 411.257 | Quarterly Revenue Growth 0.086 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.